vs
NATURES SUNSHINE PRODUCTS INC（NATR）とPagerDuty, Inc.（PD）の財務データ比較。上の社名をクリックして会社を切り替えられます
PagerDuty, Inc.の直近四半期売上が大きい（$124.5M vs $123.8M、NATURES SUNSHINE PRODUCTS INCの約1.0倍）。PagerDuty, Inc.の純利益率が高く（129.7% vs 3.3%、差は126.4%）。NATURES SUNSHINE PRODUCTS INCの前年同期比売上増加率が高い（4.7% vs 4.7%）。PagerDuty, Inc.の直近四半期フリーキャッシュフローが多い（$24.1M vs $7.6M）。過去8四半期でPagerDuty, Inc.の売上複合成長率が高い（5.9% vs 5.6%）
Natures Sunshine Products, Inc.（通称NSP）は、ハーブ、ビタミン、ミネラルを含む栄養補助食品やスキンケアなどのパーソナルケア製品の製造を行っています。本社はユタ州リーハイに置き、同州スパニッシュフォークに生産拠点を構えています。
PagerDutyはアメリカのクラウドコンピューティング企業で、IT運用部門向けのSaaS型インシデント管理プラットフォームを専門に手がけています。システム異常をリアルタイムで検知し、迅速な障害対応を支援することで、業務システムの安定稼働を支えるソリューションを提供しています。
NATR vs PD — 直接比較
損益計算書 — Q4 FY2025 vs Q3 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $123.8M | $124.5M |
| 純利益 | $4.1M | $161.6M |
| 粗利率 | 72.5% | 85.3% |
| 営業利益率 | 4.3% | 6.5% |
| 純利益率 | 3.3% | 129.7% |
| 売上前年比 | 4.7% | 4.7% |
| 純利益前年比 | 1379.4% | 2827.7% |
| EPS（希薄化後） | $0.23 | $1.69 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $123.8M | $124.5M | ||
| Q3 25 | $128.3M | $123.4M | ||
| Q2 25 | $114.8M | $119.8M | ||
| Q1 25 | $113.2M | $121.4M | ||
| Q4 24 | $118.2M | $118.9M | ||
| Q3 24 | $114.6M | $115.9M | ||
| Q2 24 | $110.6M | $111.2M | ||
| Q1 24 | $111.0M | $111.1M |
| Q4 25 | $4.1M | $161.6M | ||
| Q3 25 | $5.3M | $9.6M | ||
| Q2 25 | $5.3M | $-7.2M | ||
| Q1 25 | $4.7M | $-8.8M | ||
| Q4 24 | $-321.0K | $-5.9M | ||
| Q3 24 | $4.3M | $-10.9M | ||
| Q2 24 | $1.3M | $-17.1M | ||
| Q1 24 | $2.3M | $-28.2M |
| Q4 25 | 72.5% | 85.3% | ||
| Q3 25 | 73.3% | 84.6% | ||
| Q2 25 | 71.7% | 84.0% | ||
| Q1 25 | 72.1% | 83.6% | ||
| Q4 24 | 72.0% | 83.0% | ||
| Q3 24 | 71.3% | 82.7% | ||
| Q2 24 | 71.4% | 82.6% | ||
| Q1 24 | 71.2% | 81.7% |
| Q4 25 | 4.3% | 6.5% | ||
| Q3 25 | 7.0% | 2.9% | ||
| Q2 25 | 3.7% | -8.6% | ||
| Q1 25 | 5.4% | -9.6% | ||
| Q4 24 | 3.8% | -8.7% | ||
| Q3 24 | 4.6% | -13.8% | ||
| Q2 24 | 5.1% | -19.5% | ||
| Q1 24 | 4.2% | -30.1% |
| Q4 25 | 3.3% | 129.7% | ||
| Q3 25 | 4.2% | 7.8% | ||
| Q2 25 | 4.6% | -6.0% | ||
| Q1 25 | 4.2% | -7.2% | ||
| Q4 24 | -0.3% | -5.0% | ||
| Q3 24 | 3.8% | -9.4% | ||
| Q2 24 | 1.2% | -15.4% | ||
| Q1 24 | 2.1% | -25.3% |
| Q4 25 | $0.23 | $1.69 | ||
| Q3 25 | $0.30 | $0.10 | ||
| Q2 25 | $0.28 | $-0.07 | ||
| Q1 25 | $0.25 | $-0.12 | ||
| Q4 24 | $-0.02 | $-0.07 | ||
| Q3 24 | $0.23 | $-0.14 | ||
| Q2 24 | $0.07 | $-0.26 | ||
| Q1 24 | $0.12 | $-0.34 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $93.9M | $547.8M |
| 総負債低いほど良い | — | — |
| 株主資本純資産 | $161.6M | $320.5M |
| 総資産 | $261.1M | $1.0B |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $93.9M | $547.8M | ||
| Q3 25 | $95.6M | $567.9M | ||
| Q2 25 | $81.3M | $597.1M | ||
| Q1 25 | $86.5M | $570.8M | ||
| Q4 24 | $84.7M | $542.2M | ||
| Q3 24 | $78.7M | $599.3M | ||
| Q2 24 | $68.7M | $592.8M | ||
| Q1 24 | $77.8M | $571.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $484.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | $489.5M |
| Q4 25 | $161.6M | $320.5M | ||
| Q3 25 | $166.7M | $180.7M | ||
| Q2 25 | $163.7M | $145.7M | ||
| Q1 25 | $167.1M | $129.8M | ||
| Q4 24 | $161.0M | $111.6M | ||
| Q3 24 | $162.6M | $164.7M | ||
| Q2 24 | $156.4M | $174.0M | ||
| Q1 24 | $159.7M | $171.6M |
| Q4 25 | $261.1M | $1.0B | ||
| Q3 25 | $264.8M | $891.5M | ||
| Q2 25 | $254.9M | $926.8M | ||
| Q1 25 | $252.7M | $927.3M | ||
| Q4 24 | $240.9M | $866.8M | ||
| Q3 24 | $245.3M | $916.0M | ||
| Q2 24 | $235.8M | $924.0M | ||
| Q1 24 | $247.3M | $925.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.73× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | 2.85× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $9.9M | $24.8M |
| フリーキャッシュフロー営業CF - 設備投資 | $7.6M | $24.1M |
| FCFマージンFCF / 売上 | 6.1% | 19.3% |
| 設備投資強度設備投資 / 売上 | 1.9% | 0.6% |
| キャッシュ転換率営業CF / 純利益 | 2.41× | 0.15× |
| 直近12ヶ月FCF直近4四半期 | $28.8M | $117.6M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $9.9M | $24.8M | ||
| Q3 25 | $18.5M | $34.0M | ||
| Q2 25 | $4.3M | $30.7M | ||
| Q1 25 | $2.6M | $31.4M | ||
| Q4 24 | $12.2M | $22.1M | ||
| Q3 24 | $9.6M | $35.8M | ||
| Q2 24 | $1.3M | $28.6M | ||
| Q1 24 | $2.2M | $22.2M |
| Q4 25 | $7.6M | $24.1M | ||
| Q3 25 | $16.8M | $33.1M | ||
| Q2 25 | $3.0M | $30.2M | ||
| Q1 25 | $1.5M | $30.3M | ||
| Q4 24 | $10.0M | $21.5M | ||
| Q3 24 | $7.9M | $35.1M | ||
| Q2 24 | $-2.0M | $28.2M | ||
| Q1 24 | $-1.5M | $21.2M |
| Q4 25 | 6.1% | 19.3% | ||
| Q3 25 | 13.1% | 26.8% | ||
| Q2 25 | 2.6% | 25.2% | ||
| Q1 25 | 1.3% | 24.9% | ||
| Q4 24 | 8.5% | 18.1% | ||
| Q3 24 | 6.9% | 30.3% | ||
| Q2 24 | -1.9% | 25.4% | ||
| Q1 24 | -1.4% | 19.1% |
| Q4 25 | 1.9% | 0.6% | ||
| Q3 25 | 1.3% | 0.7% | ||
| Q2 25 | 1.2% | 0.4% | ||
| Q1 25 | 1.0% | 0.9% | ||
| Q4 24 | 1.9% | 0.5% | ||
| Q3 24 | 1.5% | 0.5% | ||
| Q2 24 | 3.0% | 0.4% | ||
| Q1 24 | 3.3% | 0.9% |
| Q4 25 | 2.41× | 0.15× | ||
| Q3 25 | 3.46× | 3.55× | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.94× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
PD
| US | $88.8M | 71% |
| Non Us | $35.7M | 29% |
